ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Because we did not monthly check the BCR-ABL1 using FISH in CML-CP patients subsequently and due to the small sample size of CML-BP patients, we only evaluated the treatment response in BCR-ABL1 positive ALL patients and survival time in CML-BP and ALL patients.